"Our decision to treat typically needs to be made on the balance of likelihood, before the diagnosis of an associated disease process can be fully established, with definitive tests for multiple ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Fampridine resulted in no significant observed ...

Multiple sclerosis (MS), a multifaceted condition influenced by both genetic and environmental factors, remains a complex diagnostic enigma, especially for diverse populations such as the Hispanic ...

The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple ...

Amit Bar-Or, MD, FRCP, FAAN, FANA: Multiple sclerosis [MS] can present with many different types of symptoms. In essence, depending on where the immune attack is in the nervous system pathways of the ...

Symptoms of MS may be mild or severe, of long duration or short, and may appear in various combinations, depending on the area of the nervous system affected. Following a relapse, complete or partial ...

Optic neuritis [ON] is generally identified as the most frequent potential risk factor associated with future development of multiple sclerosis [ms]. Whereas coherency in case of the adult disease is ...

The symptoms of MS vary widely in location and severity among individuals. Common symptoms include fatigue, numbness, focal weakness, visual changes such as unilateral visual loss and diplopia, ...

Multiple sclerosis (MS) is characterized by a broad array of symptoms. Despite this variability, most individuals with MS will exhibit a distinct set of symptoms during their initial clinical attack.